000756 新华制药
已收盘 09-28 15:00:00
资讯
新帖
简况
新华制药（000756）9月24日主力资金净卖出4015.65万元
证券之星 · 09-28 09:24
新华制药（000756）9月24日主力资金净卖出4015.65万元
新华制药（000756）9月23日主力资金净卖出2.24亿元
证券之星 · 09-24
新华制药（000756）9月23日主力资金净卖出2.24亿元
异动快报：新华制药（000756）9月23日13点58分触及跌停板
证券之星 · 09-23
异动快报：新华制药（000756）9月23日13点58分触及跌停板
新华制药：关于A股股票交易异常波动的公告
证券日报 · 09-22
新华制药：关于A股股票交易异常波动的公告
新华制药成交额创2025年11月28日以来新高
同花顺 · 09-22
新华制药成交额创2025年11月28日以来新高
A股收评：超4500股上涨！沪指涨0.97%，创新药、地产板块爆发，“华字辈”现涨停潮
格隆汇 · 09-21
A股收评：超4500股上涨！沪指涨0.97%，创新药、地产板块爆发，“华字辈”现涨停潮
异动快报：新华制药（000756）9月21日9点30分触及涨停板
证券之星 · 09-21
异动快报：新华制药（000756）9月21日9点30分触及涨停板
新华制药硫酸镁钠钾口服用浓溶液获药品注册证书
北京商报 · 09-20
新华制药硫酸镁钠钾口服用浓溶液获药品注册证书
新华制药：左卡尼汀口服溶液获得药品注册证书
南方财经网 · 09-20
新华制药：左卡尼汀口服溶液获得药品注册证书
新华制药：子公司获盐酸多奈哌齐口崩片药品注册证书
同花顺 · 09-20
新华制药：子公司获盐酸多奈哌齐口崩片药品注册证书
新华制药硫酸镁、硫酸钠、硫酸钾浓溶液口服液获药品注册证书
美股速递 · 09-18
新华制药硫酸镁、硫酸钠、硫酸钾浓溶液口服液获药品注册证书
新华制药获国家药监局批准盐酸多奈哌齐片注册
美股速递 · 09-18
新华制药获国家药监局批准盐酸多奈哌齐片注册
新华制药旗下新猫制药获盐酸多奈哌齐片药品注册证书
美股速递 · 09-18
新华制药旗下新猫制药获盐酸多奈哌齐片药品注册证书
新华制药新提交“百佳利”商标注册申请
证券之星 · 09-11
新华制药新提交“百佳利”商标注册申请
股市必读：新华制药新发布《关于阿奇霉素片通过仿制药一致性评价的公告》
证券之星 · 09-02
股市必读：新华制药新发布《关于阿奇霉素片通过仿制药一致性评价的公告》
新华制药：阿奇霉素片通过仿制药一致性评价
南方财经网 · 08-31
新华制药：阿奇霉素片通过仿制药一致性评价
新华制药最新公告：获得盐酸达泊西汀片药品注册证书
证券之星 · 08-28
新华制药最新公告：获得盐酸达泊西汀片药品注册证书
康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点；新华制药2026年上半年净利润同比下降33.35%
同花顺 · 08-27
康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点；新华制药2026年上半年净利润同比下降33.35%
新华制药（000756）2026年中报简析：净利润同比下降33.35%
证券之星 · 08-27
新华制药（000756）2026年中报简析：净利润同比下降33.35%
图解新华制药中报：第二季度单季净利润同比下降41.59%
证券之星 · 08-26
图解新华制药中报：第二季度单季净利润同比下降41.59%
加载更多
公司概况
公司名称：
山东新华制药股份有限公司
所属行业：
医药制造业
上市日期：
1997-08-06
主营业务：
山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是“新华牌”解热镇痛类药物、心脑血管类、抗感染类、中枢神经类。
发行价格：
3.45
{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":14.33,"timestamp":1790579007000,"preClose":13.92,"halted":0,"volume":61892437,"delay":0,"changeRate":0.0295,"floatShares":499000000,"shares":697000000,"eps":0.309,"marketStatus":"已收盘","change":0.41,"latestTime":"09-28 15:00:00","open":14.09,"high":14.94,"low":13.71,"amount":885000000,"amplitude":0.0884,"askPrice":14.34,"askSize":48,"bidPrice":14.33,"bidSize":3197,"shortable":0,"etf":0,"ttmEps":0.309,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790645400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.92,"symbolType":"stock","openAndCloseTimeList":[[1790559000000,1790566200000],[1790571600000,1790578800000]],"highLimit":15.31,"lowLimit":12.53,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":696683435,"isCdr":false,"pbRate":1.84,"roa":"--","peRate":46.375405,"roe":"2.81%","epsLYR":0.42,"committee":0.686342,"marketValue":9983000000,"turnoverRate":0.1241,"status":0,"hkstockBrief":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":5.69,"timestamp":1790582906359,"preClose":5.77,"halted":0,"volume":2424000,"delay":0,"premium":"-66.04"},"floatMarketCap":7149000000},"requestUrl":"/m/hq/s/000756","defaultTab":"news","newsList":[{"id":"2670721407","title":"新华制药（000756）9月24日主力资金净卖出4015.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670721407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670721407?lang=zh_cn&edition=full","pubTime":"2026-09-28 09:24","pubTimestamp":1790558672,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，新华制药报收于13.92元，下跌4.2%，换手率13.9%，成交量69.32万手，成交额9.92亿元。近5日资金流向一览见下表：新华制药融资融券信息显示，融资方面，当日融资买入8955.11万元，融资偿还8727.02万元，融资净买入228.09万元。融券方面，融券卖出2000.0股，融券偿还0.0股，融券余量6.68万股，融券余额92.98万元。新华制药主营业务：开发、制造和销售化学原料药、制剂、医药中间体及其他产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800002939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669943044","title":"新华制药（000756）9月23日主力资金净卖出2.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669943044","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669943044?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:12","pubTimestamp":1790212347,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，新华制药报收于14.53元，下跌9.98%，跌停，换手率17.45%，成交量87.03万手，成交额13.33亿元。近5日资金流向一览见下表：新华制药融资融券信息显示，融资方面，当日融资买入9616.67万元，融资偿还1.19亿元，融资净偿还2263.99万元。新华制药主营业务：开发、制造和销售化学原料药、制剂、医药中间体及其他产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162170","title":"异动快报：新华制药（000756）9月23日13点58分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162170","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669162170?lang=zh_cn&edition=full","pubTime":"2026-09-23 14:00","pubTimestamp":1790143254,"startTime":"0","endTime":"0","summary":"证券之星9月23日盘中消息，13点58分新华制药（000756）触及跌停板。其所属行业化学制药目前下跌。领涨股为艾力斯医药科技。该股为创新药，维生素，合成生物概念热股，当日创新药概念上涨0.51%。9月22日的资金流向数据方面，主力资金净流入1.15亿元，占总成交额7.36%，游资资金净流出1.12亿元，占总成交额7.15%，散户资金净流出329.43万元，占总成交额0.21%。近5日资金流向一览见下表：新华制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300020734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147881","title":"新华制药：关于A股股票交易异常波动的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147881","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669147881?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:53","pubTimestamp":1790081580,"startTime":"0","endTime":"0","summary":"证券日报网讯9月22日，新华制药发布公告称，公司2026年9月18日、9月21日、9月22日A股股票连续三个交易日收盘价格涨幅偏离值累计达到20%，根据深圳证券交易所的有关规定，属于股票交易异常波动的情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609223881449949.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609223881449949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["399300","02846","82846","03188","07233","83188","000756","BK0164","BK0239","BK1147","159982","83130","03130","02827"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669719084","title":"新华制药成交额创2025年11月28日以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2669719084","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669719084?lang=zh_cn&edition=full","pubTime":"2026-09-22 10:39","pubTimestamp":1790044740,"startTime":"0","endTime":"0","summary":"数据宝统计，截至09:57，新华制药成交额10.03亿元，创2025年11月28日以来新高。最新股价上涨10.02%，换手率12.47%。上一交易日该股全天成交额为3.09亿元。据天眼查APP显示，山东新华制药股 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260922/c680157445.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260922/c680157445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669580151","title":"A股收评：超4500股上涨！沪指涨0.97%，创新药、地产板块爆发，“华字辈”现涨停潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2669580151","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669580151?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:05","pubTimestamp":1789974303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0164","BK0113","LU0501845795.SGD","LU1781817850.SGD","BK0183","LU1226287529.USD","LU1993786604.SGD","LU0072913022.USD","LU0880133367.SGD","BK0190","BK0188","BK0095","000756","BK0216","BK0187","000001","IE00B0JY6N72.USD","LU1655091616.SGD","600664","BK0102","BK0028","002285","LU1807302812.USD","BK0012","LU1580142542.USD","00719","BK0201","600721","BK0278","LU0067412154.USD","BK0239","BK0273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136110","title":"异动快报：新华制药（000756）9月21日9点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669136110?lang=zh_cn&edition=full","pubTime":"2026-09-21 09:36","pubTimestamp":1789954590,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息，9点30分新华制药（000756）触及涨停板。其所属行业化学制药目前上涨。领涨股为华纳大药厂。该股为创新药，化学原料药，医药概念热股，当日创新药概念上涨1.85%，化学原料药概念上涨1.69%，医药概念上涨1.61%。9月18日的资金流向数据方面，主力资金净流入2326.37万元，占总成交额11.01%，游资资金净流出1162.31万元，占总成交额5.5%，散户资金净流出1164.06万元，占总成交额5.51%。近5日资金流向一览见下表：新华制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100003218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668181350","title":"新华制药硫酸镁钠钾口服用浓溶液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2668181350","media":"北京商报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668181350?lang=zh_cn&edition=full","pubTime":"2026-09-20 20:36","pubTimestamp":1789907798,"startTime":"0","endTime":"0","summary":"9月20日晚间，新华制药（000756）披露公告称，公司收到国家药品监督管理局核准签发的硫酸镁钠钾口服用浓溶液《药品注册证书》。本品适用于成人，用于任何需要清洁肠道的操作前的肠道清洁。公告显示，本品为《国家基本医疗保险、工伤保险和生育保险药品目录（2025年）》乙类品种。根据相关统计数据，2025年中国公立医疗机构硫酸镁钠钾口服用浓溶液销售额约为4.9亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609203879434916.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609203879434916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668183976","title":"新华制药：左卡尼汀口服溶液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2668183976","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668183976?lang=zh_cn&edition=full","pubTime":"2026-09-20 15:39","pubTimestamp":1789889944,"startTime":"0","endTime":"0","summary":"南财智讯9月20日电，新华制药公告，公司收到国家药品监督管理局签发的左卡尼汀口服溶液《药品注册证书》。该产品用于治疗原发性系统性卡尼汀缺乏症（临床表现包括反复发作的Reye样脑病、低酮性低血糖症和/或心肌病等）以及先天性代谢异常导致的继发性卡尼汀缺乏症的短期和长期治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609203879360891.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609203879360891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668183987","title":"新华制药：子公司获盐酸多奈哌齐口崩片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2668183987","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668183987?lang=zh_cn&edition=full","pubTime":"2026-09-20 15:38","pubTimestamp":1789889880,"startTime":"0","endTime":"0","summary":"每经AI快讯，9月20日，新华制药公告称，公司全资子公司新达制药收到国家药监局核准签发的盐酸多奈哌齐口崩片《药品注册证书》。该药品用于轻度、中度或重度阿尔茨海默病症状的治疗，属于医 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260920/c680091634.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260920/c680091634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182098371","title":"新华制药硫酸镁、硫酸钠、硫酸钾浓溶液口服液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1182098371","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182098371?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:01","pubTimestamp":1789722068,"startTime":"0","endTime":"0","summary":"山东新华制药股份有限公司宣布，其研发的硫酸镁、硫酸钠、硫酸钾浓溶液口服液已成功获得药品注册证书。此举标志着该公司在医药领域的又一重要进展，进一步丰富了其产品线布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","000756","BK0164","00719","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101995774","title":"新华制药获国家药监局批准盐酸多奈哌齐片注册","url":"https://stock-news.laohu8.com/highlight/detail?id=1101995774","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101995774?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:59","pubTimestamp":1789721950,"startTime":"0","endTime":"0","summary":"新华制药（Shandong Xinhua Pharmaceutical Co）传来最新进展——其盐酸多奈哌齐片已获得国家药品监督管理局的注册批准。这标志着该产品在合规性与临床适用性上通过了监管层的严格审视，距正式投放市场更近一步。据悉，该药品此番获批，为公司产品线再添新的增长点。此次审批的通过，也为新华制药在神经系统用药领域的战略布局夯实了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719","BK1515","BK1191","000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103544505","title":"新华制药旗下新猫制药获盐酸多奈哌齐片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1103544505","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103544505?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:59","pubTimestamp":1789721949,"startTime":"0","endTime":"0","summary":"新华制药（000756.SZ；00719.HK）旗下新猫制药近日取得盐酸多奈哌齐片的药品注册证书。这一进展标志着该公司在神经系统药物领域的产品线再添新丁。盐酸多奈哌齐片主要用于治疗阿尔茨海默病相关症状，市场前景广阔。此次获证，无疑为新华制药抢占该细分市场份额奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719","BK0239","BK1191","000756","BK1515","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666834511","title":"新华制药新提交“百佳利”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666834511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666834511?lang=zh_cn&edition=full","pubTime":"2026-09-11 07:15","pubTimestamp":1789082110,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日山东新华制药股份有限公司新提交“百佳利”商标注册申请。商标申请详情如下：今年以来山东新华制药股份有限公司新申请注册商标16件，截止目前公司共持有注册商标753件，另有95件商标尚在注册申请中。通过天眼查大数据分析，山东新华制药股份有限公司共对外投资了19家企业，参与招投标项目14041次；财产线索方面有商标信息578条，专利信息611条，著作权信息1条；此外企业还拥有行政许可1083个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100013373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863910","title":"股市必读：新华制药新发布《关于阿奇霉素片通过仿制药一致性评价的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863910","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664863910?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:36","pubTimestamp":1788284173,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资子公司阿奇霉素片通过仿制药一致性评价，该产品为医保甲类品种，2025年公立医疗机构销售额约6.7亿元。公司公告汇总关于阿奇霉素片通过仿制药一致性评价的公告山东新华制药股份有限公司全资子公司山东淄博新达制药有限公司收到国家药品监督管理局核准签发的阿奇霉素片《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200001957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076882","title":"新华制药：阿奇霉素片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076882","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663076882?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:51","pubTimestamp":1788166260,"startTime":"0","endTime":"0","summary":"南财智讯8月31日电，新华制药公告，其全资子公司山东淄博新达制药有限公司收到国家药监局核准签发的《药品补充申请批准通知书》，阿奇霉素片通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860136938.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860136938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662996065","title":"新华制药最新公告：获得盐酸达泊西汀片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2662996065","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662996065?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:32","pubTimestamp":1787909555,"startTime":"0","endTime":"0","summary":"新华制药(000756.SZ)公告称，公司收到国家药监局核准签发的盐酸达泊西汀片《药品注册证书》，该药品适用于治疗18至64岁男性早泄患者。2025年中国公立医疗机构达泊西汀销售额约10.3亿元。此次获批将进一步丰富公司制剂产品线，提升市场竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728077","title":"康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点；新华制药2026年上半年净利润同比下降33.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728077","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662728077?lang=zh_cn&edition=full","pubTime":"2026-08-27 07:01","pubTimestamp":1787785260,"startTime":"0","endTime":"0","summary":"丨2026年8月27日星期四丨 NO.1康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点8月26日晚间，康方生物宣布，公司全球首创的肿瘤免疫2.0基石药物依沃西联合化疗方案，对比度伐利尤单 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260827/c679322298.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260827/c679322298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662402417","title":"新华制药（000756）2026年中报简析：净利润同比下降33.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662402417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662402417?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:22","pubTimestamp":1787782975,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期新华制药发布2026年中报。根据财报显示，新华制药净利润同比下降33.35%。截至本报告期末，公司营业总收入43.58亿元，同比下降6.06%，归母净利润1.49亿元，同比下降33.35%。按单季度数据看，第二季度营业总收入19.34亿元，同比下降12.43%，第二季度归母净利润6522.45万元，同比下降41.59%。去年的净利率为3.5%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700011550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751827","title":"图解新华制药中报：第二季度单季净利润同比下降41.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751827","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662751827?lang=zh_cn&edition=full","pubTime":"2026-08-26 02:15","pubTimestamp":1787681725,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药2026年中报显示，上半年度公司主营收入43.58亿元，同比下降6.06%；归母净利润1.49亿元，同比下降33.35%；扣非净利润1.47亿元，同比下降30.14%；其中2026年第二季度，公司单季度主营收入19.34亿元，同比下降12.43%；单季度归母净利润6522.45万元，同比下降41.59%；单季度扣非净利润6701.79万元，同比下降36.68%；负债率39.32%，投资收益736.31万元，财务费用3049.52万元，毛利率19.16%。财报数据概要请见下图:本文数据来源于新华制药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600005041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790642892462,"stockEarnings":[{"period":"1week","weight":-0.0232},{"period":"1month","weight":0.067},{"period":"3month","weight":0.0226},{"period":"6month","weight":-0.0429},{"period":"1year","weight":-0.0805},{"period":"ytd","weight":-0.0596}],"compareEarnings":[{"period":"1week","weight":-0.032},{"period":"1month","weight":-0.0325},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0316},{"period":"1year","weight":-0.0012},{"period":"ytd","weight":-0.0366}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"79848人(较上一季度增加Infinity%)","perCapita":"6247股","listingDate":"1997-08-06","address":"山东省淄博市张店区高新区鲁泰大道1号","registeredCapital":"69668万元","survey":" 山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是“新华牌”解热镇痛类药物、心脑血管类、抗感染类、中枢神经类。","listedPrice":3.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}